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Summary
Polychlorinated biphenyls (PCBs), 2,2-bis(p-chlorophenyl)-1,1,1-trichloroethane (p,p’-DDT) and
2,2-bis(p-chlorophenyl)-1,1-dichloroethylene (p,p’-DDE), the most stable metabolite of p,p’-DDT,
are persistent organic pollutants and environmental endocrine disruptors. Infant exposure to these
chemicals through breast feeding may influence children’s growth, but this potential adverse effect
could be complicated by the co-existing benefits of breast feeding. This study examined the
associations between lactational exposure to these chemicals and infant growth in the first 12
months by using data from the Pregnancy, Infection and Nutrition Babies Study in central North
Carolina, United States, 2004–2006. The study population was restricted to the infants who were
breastfed for 6 months or longer. PCBs, p,p’-DDT and p,p’-DDE were measured in breast milk at
3 months postpartum. Lactational exposure through 12 months was estimated as the product of
chemical concentrations and the duration of breast feeding. The infant’s weight and length were
recorded from the medical record for each routine pediatric well-child visit in the first 12 months.
Women-child pairs who breastfed for 6 months or longer and returned the growth card (n=210),
were included in the study. Linear mixed effects models were used to assess the associations
between chemical concentrations in breast milk and longitudinal infant weight and length
measurements in the first 6 months. Multivariable linear regression models were used to assess the
relationships between lactational exposure to chemicals through 12 months and the z-scores of
infant weight, length and weight-for-length at 12 months. Overall, no association was observed.
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Breast feeding for 6 months or longer, with lactational exposure to PCBs, p,p’-DDT and p,p’-DDE
at the low background level concentrations studied here, results in no measurable influence on
infant growth in the first 12 months.
INTRODUCTION
The first 12 months of life is a period of dramatic change in babies’ physical growth. Infants
gain weight at a rate of about 680g per month during the first 5 to 6 months 1. By the end of
the first year, weight triples, and body length increases by approximately 50% 1. Growth in
infancy has been related to long-term outcomes such as children’s cognition, pubertal
development, adult obesity, chronic diseases, and workplace success 2–9. Infant growth
retardation can be due to intrauterine growth inhibition, early childhood diseases,
malnutrition, or disruption of hormone systems, potentially caused by environmental
pollutants.
Polychlorinated biphenyls (PCBs), 2,2-bis(p-chlorophenyl)-1,1,1-trichloroethane (p,p’-
DDT) and its most stable metabolite, 2,2-bis(p-chlorophenyl)-1,1-dichloroethylene (p,p’-
DDE), are persistent organic compounds in the environment, which have been recognized as
endocrine disruptors 10. In vivo and in vitro studies have shown that PCBs may alter
dopamine, estrogen and thyroid effects 11–14. p,p’-DDT has been suspected to have
estrogenic effects, and p,p’-DDE is known as an antiandrogen 15–19. The potential for these
compounds to interfere with the endocrine system could adversely affect infant development
and growth.
The main route of exposure to PCBs, p,p’-DDT and p,p’-DDE for infants is through breast
feeding. As the duration of lactation increases, the infant’s accumulated dose of these long
half-life chemicals increases. Exclusive breast feeding up to 6 months postpartum is
recommended by the World Health Organization (WHO) because breast milk provides
essential nutrients that an infant needs for growth and development 20. Assessing the
adverse effects of chemical exposure through breast feeding is thus complicated by the co-
existing beneficial attributes. In addition, breast-fed infants compared to formula-fed infants
generally gain less weight in the first twelve months without much difference in length 21,
22. Breast feeding per se could affect infant growth.
This study estimated the relationships between lactational exposure to PCBs, p,p’-DDT and
p,p’-DDE and infant growth in the first 12 months using two methods. First, the study
population was restricted to the infants who were breastfed for 6 months or longer to make
breast feeding duration in the first 6 months uniform across the sample. This allowed us to
assess the effects of chemical exposure on growth in the first 6 months independently from
effects of breast feeding duration. Second, the effects of exposure to the accumulated
chemicals over the first 12 months of life were examined, incorporating duration of breast
feeding into an exposure metric.
MATERIALS AND METHODS
Study population
The Pregnancy, Infection and Nutrition (PIN) Babies Study followed the infants of the PIN
and PIN Postpartum Study participants from January 2004 to the end of 2006. These studies
enrolled pregnant women receiving prenatal care at the University of North Carolina
Hospitals before 20 weeks gestation and followed them through the first year postpartum.
Mothers completed several self-administered questionnaires and two phone interviews
during pregnancy, one brief questionnaire after delivery in the hospital, and two in-home
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interviews at 3 and 12 months postpartum to provide details about their health and lifestyle
during and after pregnancy. Infants in the PIN Babies studies were singletons without major
birth defects. Details of these studies are available at the website:
http://www.cpc.unc.edu/projects/pin/. The protocols of all the PIN studies have been
approved by the Institutional Review Board of the University of North Carolina at Chapel
Hill, and written informed consent was obtained from all participating mothers.
Three hundred and four of the participant women in the PIN Babies Study (n=585) were still
lactating at 3 months postpartum and willing to provide a valid breast milk sample. They
followed the written instructions to pump both breasts at around 10 o'clock in the morning
of the scheduled interview. They gently mixed the milk extracted, used the plastic pipette to
transfer the milk into three 1.5ml tubes, and stored the milk in the freezer until the
interviewers arrived. Samples were then transported on ice to the −80 °C storage freezers.
Two hundred and sixty-four of the 304 women continued participation in the postpartum 12-
month in-home interview. Infant feeding methods for each preceding month was reported at
these two home interviews 3 and 12 months postpartum (as further described below). Two
hundred and fifty-three women were thus identified as breast feeding for 6 months or longer
in the first year.
Growth measurement
Mothers were provided with an infant growth card to take to their child’s 12-month pediatric
well-child visit. The children’s medical care providers completed the growth card by
abstracting the infant’s weight and length at each routine clinical visit from birth through 12
months from the medical record. The schedule for visits recommended by the American
Academy of Pediatrics is at 1, 2, 4, 6, 9, and 12 months of age, but actual dates of visits
were recorded because the frequency and times of visits varied among infants. The growth
card was then collected at the 12-month home visit.
The weights and lengths of infants were compared to nationally representative data, the
2000 Centers for Disease Control and Prevention (CDC) growth charts, to determine their
age-and gender-standardized z-scores of weight, length and weight-for-length 23. Growth
measurements were considered as biologically implausible if the z-scores were in the fixed
exclusion range suggested by the World Health Organization 24. The 2000 CDC growth
charts were based on a mix of both breast-fed and formula-fed infants, in which only 33% of
infants were breast-fed for 3 months or longer. In general, the weights of the infants in this
study were likely to be on the “light” side on the 2000 charts because the entire sample
breastfed for 6 months or longer.
Exposure measurement
Breast milk samples were analyzed for p,p’-DDT, p,p’-DDE and thirty-five PCB congeners
according to the existing methodology at the Organic Analytic Toxicology Branch of the
National Center for Environmental Health at the CDC 25. The measurement of selected
chemicals in breast milk samples was performed using gas chromatography/isotope dilution
high-resolution mass spectrometry (GC/IDHRMS) using a MAT95 instrument
(ThermoFinnigan MAT; Bremen, Germany). The lipid concentration was gravimetrically
determined by an analytical balance AX105 Delta Range (Mettler Toledo; Columbus, OH)
with an accuracy of ±10−4 g. Each analysis batch contained sixteen unknowns, two method
blanks and two quality control specimens. The between-assay coefficient of variation was
normally less than 10%. Concentrations reported here were all lipid adjusted. PCB153 and
p,p’-DDE were detected in all 304 samples, and p,p’-DDT was detected in 292 samples
(96%). Total PCBs was calculated as the sum of the eighteen PCB congeners that were
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detectable in more than 70% of samples, that is PCBs 66, 74, 99, 105, 118, 138_158, 146,
153, 156, 170, 177, 178, 180, 183, 187, 194, 196_203 and 199. Concentrations lower than
the limits of detection (LOD) were imputed to the median of the method LOD of each
measurement divided by the square root of 2 26.
Lactational exposure metric
In addition to using the lipid-adjusted chemical concentrations measured in breast milk at
three months postpartum as an infant’s exposure measurement, a Lactational Exposure
Metric (LEM), a function of the lipid-adjusted chemical concentration in breast milk and the
durations of breast feeding, was developed to represent an infant’s cumulative exposure to
each chemical at 12 months.
Durations of breast feeding were estimated from the two home interviews at 3 and 12
months postpartum. At these two interviews, women were asked to recall their feeding
practices for each of the preceding months, indicating the frequency that they breastfed, fed
infant formula, and fed other types of food. For each month, feeding status was classified.
Exclusively breast feeding was defined as breast feeding with no other food or liquid; mostly
breast feeding was defined as breast feeding with feeding of other supplements ≤1 time per
day; and breast feeding with supplements was defined as breast feeding with feeding any
other liquids or solids >1 time per day. The number of months representing each type of
feeding was summed and used in LEM.
The LEM was developed as follows:
in which C denotes lipid-adjusted chemical concentration in breast milk (ng/g lipid), D1 is
duration of exclusively breast feeding (months), D2 is duration of mostly breast feeding
(months), and D3 is duration of breast feeding with supplements (months). The unit of this
estimate is concentration-months, i.e. (ng/g)-months. Using this metric, breast milk
concentration for each chemical was assumed to be constant through the lactation period,
and breast milk consumption was assumed to be decreased by half during the period of
breast feeding with supplements.
Statistical analysis
To estimate the relationships between lactational exposure to PCBs, p,p’-DDT and p,p’-
DDE and infant growth, two statistical analyses were conducted using PC-SAS (version
9.1). In the first analysis, linear mixed effects models (PROC MIXED) were used to assess
the relations between PCB153, total PCBs, p,p’-DDT and p,p’-DDE concentration in breast
milk and longitudinal infant weight (grams) and length (centimeters) measurements in the
first 6 months 27. The concentrations of PCB153, total PCBs, p,p’-DDT and p,p’-DDE in
breast milk at 3 months postpartum were included in the separate mixed models as time-
independent variables. Infant age at the pediatric well-child visits was a time dependent
variable, and centered at 90 days. A linear term, a quadratic term and a cubic term of infant
age at the visit were included in the model to allow a curvilinear growth pattern. Models also
included a random intercept and a random slope for infant age to allow infants to have their
own growth patterns. The interaction terms between infant age and gender, between infant
age and preterm status, between infant age and maternal race, and between infant gender and
the concentrations of chemicals were added in the models and assessed by likelihood ratio
tests using maximum likelihood. The a priori α-level for interaction tests was 0.1. The
rationale for including the interaction terms between infant age and gender, between infant
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age and preterm status, and between infant age and maternal race was to allow the infant
growth curves vary by gender, preterm status and race. The rationale for including the
interaction term between infant gender and the chemical concentration was to examine
whether the chemical’s effect estimate was modified by gender, which was once reported in
the literature. Influence statistics were assessed to examine how observations impacted the
effect estimators 28. The parameters in the final models were estimated using restricted
maximum likelihood. Other covariates, which were included in the final model as time-
independent variables, were potential confounders and the important determinants of the
outcomes: infant gender (male vs. female), preterm birth (yes vs. no), birthweight (grams),
maternal race (nonwhite vs. white), education (<16 years vs. ≥16 years), income as a
percentage of the poverty level during pregnancy (100%), parity (0 vs. ≥1), and maternal
pre-pregnancy body mass index (kg/m2).
In the second analysis, multivariable linear regression models were used to assess the
relationships between lactational exposure to PCB153, total PCBs, p,p’-DDT and p,p’-DDE
through 12 months, which was estimated by LEM, and the z-scores of infant weight, length
and weight-for-length at 12 months. Infants who had a growth measurement in the interval
12±1.5 months were included in this analysis. If there were multiple measurements within
this range, we used the one measured at the age closest to 12 months. To control the
confounding effects from breast feeding, we first modeled the associations between the
duration of breast feeding and z-scores of weight, z-scores of length and z-scores of weight-
for-length separately using simple linear regression. The residuals of the simple linear
regression models were then included in the multiple linear regression models as dependent
variables to estimate the effects of the LEM. Other covariates included in the linear
regression models were z-score of birthweight, preterm birth (yes vs. no), maternal race
(nonwhite vs. white), education (<16 years vs. ≥16 years), income as a percentage of the
poverty level during pregnancy (100%), parity (0 vs. ≥1) and maternal pre-pregnancy body
mass index (kg/m2). Gender and LEM interaction was included in the models and assessed
by the likelihood ratio test (a priori α-level = 0.10). Robust regression with Least Trimmed
Squares (LTS) estimation for multiple linear regression models was used to examine the
influence on beta coefficients by the outliers of chemical concentrations 29.
RESULTS
Among 253 women who breastfed for 6 months or longer, 210 women returned the growth
card. The study population was primarily white women with 16 or more years of education
who were about 31 years of age at the start of pregnancy (Table 1). Comparison of the 210
mother-child pairs in the growth card subgroup with the original 304 participants showed
that those who breastfed for 6 months or longer and also participated in the follow-up
studies were more highly educated and more likely to be white women. However, this
subgroup had similar distributions of chemical concentrations and LEMs to those of the
original population. In the subgroup of 210 mother-child pairs, one infant had no records of
clinical visits in the first 6 months and was not included in the mixed models; 9 infants had
no clinical visits around 12 months and were not included in the linear regression models.
Children averaged 3.7 (range 1 to 7) well-child visits in the first 6 months. A total of 774
visits for 209 infants were included in the analysis; 537 of these 774 visits occurred before
the age of 3 months. After controlling for other covariates in the mixed models, the growth
curves of infant weight and length through 6 months were not related to the concentrations
of PCB153, total PCBs, p,p’-DDT and p,p’-DDE (Table 2). Excluding the chemical
concentration outliers, i.e. >mean+3 standard deviations (SD), (2 infants for analysis of
PCB153, 3 for total PCBs, and 4 for p,p’-DDT and p,p’-DDE) only changed the magnitudes
of effect estimates (βs) by 11.1 (for PCB153), 5.2 (for total PCBs), 46.4 (for DDT) and 2.7
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(for DDE) in the mixed models for body weight (grams) and changed the magnitudes of
effect estimates (βs) by 0.01 or less in the mixed models for body length (centimeters). All
the confidence intervals (CI) of the associations became wider and still remained inclusive
of zero (data not shown). Quadratic and cubic terms of the chemical concentration were
considered to examine the possibility of curvilinear associations; but because they were not
statistically significant and complicated the interpretation, they were excluded in the final
models.
The interaction terms between infant age and gender, infant age and preterm status, and
infant age and maternal race contributed to the fit of the models, which indicated the growth
curves of weight in the first 6 months varied by gender, preterm status and maternal race;
however, in the models of length, the growth curves did not vary by maternal race. The
likelihood ratio tests for the interaction between the chemical concentrations and gender had
p-values greater than 0.1, so the effects of chemicals were not modified by infant gender.
At twelve months, the mean weight of 201 infants who had medical visits at 12 months was
9,581 grams (SD = 1,128) and the mean z-score of weight was −0.50 (SD = 1.03). The mean
length was 75.7 centimeters (SD = 2.7) and the mean z-score of length was 0.17 (SD =
0.88). The mean z-score of weight-for-length was −0.26 (SD = 1.16). As the duration of
breast feeding increased by a month, the z-scores of weight, length and weight-for-lengths at
12 months decreased by 0.12 (P < 0.001), 0.06 (P = 0.06) and 0.10 (P < 0.01) respectively.
Table 3 shows that after covariate adjustment, no differences in z-scores of weight, length,
or weight-for-length were observed with increases in LEM of PCB153, PCBs, p,p’-DDT and
p,p’-DDE. Gender did not modify measurements of the LEM effect, except for the
interaction term between p,p’-DDT and gender in the model of infant weight (P = 0.07).
However, the effect estimates of p,p’-DDT stratified by infant gender were still inclusive of
0 (male: β = −0.0229 [95%CI = −0.0602, 0.0144]; female: β = 0.0122 [95%CI = −0.0218,
0.0462]). Robust regression identified 1 to 3 outliers (0.5 to 1.5 %) in the multivariable
linear regression models, but results remained unchanged. Quadratic and cubic terms of the
LEM were considered to examine the possibility of curvilinear associations; but because
they were not statistically significant and complicated the interpretation, they were excluded
in the final models.
DISCUSSION
Our results suggest that among infants breastfed for 6 months or longer, there was no
difference in weight and length through the first 6 months as the concentration of PCBs,
p,p’-DDT and p,p’-DDE in breast milk increased. No difference was observed in weight,
length and weight-for-length at 12 months when comparing the accumulated lactational
exposure through 12 months after controlling for total duration of breast feeding. No sex-
specific association was observed.
The associations between PCBs, p,p’-DDT and p,p’-DDE and children’s growth have not
been consistent throughout the literature, nor has the effect modification of gender.
Inconsistent results may be due to different exposure periods assessed (prenatal, lactational
or childhood), different chemical concentration distributions in the study populations,
different mixtures of environmental chemicals across studies, or inadequate confounding
control for duration of breast feeding. This study measured chemical concentrations in breast
milk at 3 months postpartum to examine the effects of infants’ lactational exposure. The
study population was exposed to low background levels reflected by the relatively lower
chemical concentrations compared to other previous studies. Because breast feeding itself
can affect growth patterns, we restricted the analyses to those breastfed for 6 months or
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longer. This restriction should have minimized the potential for confounding by the duration
of breast feeding.
Despite different methods of exposure estimation and different time windows of outcome
measurements, this study supported previous findings of no association between children’s
growth and postnatal exposure to PCBs 30–32. Our results contrast those from the Faroe
Islands cohort study, which suggested an increase in lactational exposure, estimated by the
product terms of chemical concentrations and the duration of exclusive breast feeding,
decreased body height and weight at 18 months 33. PCB153 concentrations in breast milk
from the women in Faroe Islands were on the order of more than 20 times greater than those
in our study 34. As for prenatal exposure to PCBs in previous studies, children with higher
prenatal PCBs were reported to be shorter from birth to 3 months of age in a formula-fed
group in the Dutch cohort 31, but higher prenatal PCBs were associated with greater height
among 5-year-old girls in the California study 35. A negative association with body weight
was observed only among girls in the small subset of the Collaborative Perinatal Project
(CPP) cohort in New York 36 and in a Michigan cohort of polybrominated biphenyl
accident victims 37. This negative association was found without gender differentiation
among 4-year-old children in the Michigan fish consumption cohort 30, and from birth to 3
months in a formula-fed group in the Dutch cohort 31. However, two other studies reported
that no difference was observed in children’s growth when prenatal exposure to PCBs
increased 38, 39.
No prior studies have investigated lactational exposure to p,p’-DDT and p,p’-DDE in
relation to infant growth. In several studies of prenatal exposure to p,p’-DDT and p,p’-DDE,
no difference was observed in children’s growth 36, 39, 40. However, the CPP cohort found
a negative association between prenatal p,p’-DDE and children’s height at 1, 4, and 7 years
38. This negative association was also found only among girls in the German study using the
concentrations detected in children’s blood at 8 years of age to index perinatal exposure 32.
There were about 5% of women smoking postpartum in the PIN Babies Study, so this study
had limited statistical power to examine the interaction between DDE and maternal smoking
on children’s growth suggested by the Belgian study 41.
In this study, the concentration of PCB153, the most prevalent congener, was highly
correlated with the concentrations of mono-ortho-chlorinated PCBs, di-ortho-chlorinated
PCBs, and tri-ortho-chlorinated PCBs; the Pearson correlation coefficients were 0.76, 0.99,
and 0.80 respectively. Thus, it is unlikely that using ortho-substituted groupings of PCB
congeners would provide different results from using PCB153 only. Indeed, no associations
were found when analyzing data using ortho-substituted groupings of PCB congeners. In
addition, providing the effect estimates of single PCB153 concentration would facilitate the
comparisons across studies. Plíšková et al. reported that PCBs 138, 153, 170, 180, 187, 194,
199 and 203 in ER-CALUX assay showed antiestrogenic effects 42. By grouping PCB
congeners based on suggested antiestrogenicity, the magnitude of the association between
PCBs and infant weight in the first 6 months became smaller than with PCB153 only (β in
the mixed model = −8.4 [−16.6, −0.25]) and the estimate was at the borderline of
significance (P=0.04). No other associations were found.
The lactational exposure metrics used in this study can reflect an infant’s accumulated
lactational exposure through the first 12 months. According to the Hooper et al study 43, the
PCB153 concentration in breast milk decreased 4% over the first 6 months of breast feeding;
after 6 months, the PCB153 concentration did not change more than 1% per month. Among
83 women in our study who had concentrations available in both 3-month and 12-month
breast milk samples, there was no statistical difference in the concentrations of PCB153,
PCBs, p,p’-DDT and p,p’-DDE. These findings support the assumption of a relatively
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constant concentration throughout the lactation period. Additionally, under the two
assumptions that infants in the same feeding status group consumed similar amounts of
breast milk and that the mothers had similar fat composition in their breast milk, the LEM
should be highly correlated with the absolute value of the accumulated dose of the
chemicals. Although the LEM is appropriate for estimating the relative effects of chemical
exposure, results using this method may still be affected by the potential for non-differential
exposure misclassification based on our assumptions and recall errors. Such bias would tend
to shift effect estimates toward the null.
For the investigation on the growth trajectory in the first 6 months, the concentration of
chemicals in breast milk was used in the mixed models. This measurement should be highly
correlated with the accumulated exposure through the first 6 months because all the infants
in this study were breastfed for at least 6 months and 90% of the infants were exclusively or
mostly breastfed for 4 months or longer. This selection criterion provided comparability
among the infants, and also provided an unambiguous measure of the chemical effect
independent of the duration of breast feeding. We also used the LEM at each pediatric well-
child visit as a time-dependent variable in the mixed models, and the findings confirmed the
results of no association.
The logarithmic transformation of the concentrations of PCB153, total PCBs, p,p’-DDT and
p,p’-DDE was considered for the general linear mixed models, but it did not substantially
improve the normality of residuals or reduce leverage points. We decided to use a linear
term of the concentrations in the models for simplicity and ease of interpretation.
Several limitations of this study should be noted. This study population was primarily well-
educated white mothers, which may constrain the generalization of the findings, especially if
the heterogeneous effects of race and socioeconomic status were believed to be true. There
were no direct measurements of prenatal exposure to PCBs, p,p’-DDT and p,p’-DDE in this
study, thus the effects of lactational exposure could not be differentiated from the effects of
prenatal exposure. However, we adjusted for infant birthweight in the mixed models and
adjusted the z-scores of birthweight in the multiple linear regression models to control for
the potential adverse effects of prenatal exposure on intrauterine growth.
Women have been encouraged to breastfeed for at least 6 months by the WHO and the
American Academy of Pediatrics. Although longer durations of breast feeding may involve
increased exposure to potentially hazardous chemicals, our study indicates that breast
feeding for 6 months or longer, with lactational exposure to PCBs, p,p’-DDT and p,p’-DDE
in the ranges of low background level concentrations studied here, results in no measurable
influence on infant growth in the first 12 months.
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Table 1
Characteristics and Chemical Concentrations in Breast Milk of Participant Mothers Who Provided Breast Milk
at 3 Months in the PIN Babies Study and also of the Mother-Child Pairs Included in this Paper, Central North





No. % No. %
Maternal characteristics
Race
  White 262 86 189 90
  Non-white 42 14 21 10
Education (years)
  <16 54 18 28 13
  ≥16 250 82 182 87
Parity
  0 160 53 107 51
  ≥1 144 47 103 49
Age (years)
  Mean (SD) 31 (5) 31 (5)
Percent of 2001 poverty level
during pregnancy (%)
  Mean (SD) 490 (199) 509 (186)
  Missing 5 4
Pre-pregnancy body mass index
(kg/m2)
  Mean (SD) 23.8 (4.9) 23.5 (4.8)
Median (range) of chemical
concentrations in breast milk
(ng/g lipid) a
  PCB153 17 (2–199) 18 (2–199)
  ΣPCBs b 77 (9–708) 81 (12–708)
  p,p’-DDT 5 (<LOD-80) 5 (<LOD-36)
  p,p’-DDE 121 (1–2,140) 113 (15–2,140)
Infant characteristics
Baby gender
  Male 163 54 113 54
  Female 141 46 97 46
Preterm birth
  Yes 22 7 16 8
  No 282 93 194 92
Birthweight (g)
  Mean (SD) 3406 (624) 3358 (474)
Duration of breast feeding
(months)
  Mean (SD) 10 (2) 11 (2)


















No. % No. %
  Missing 40 0
Months of exclusive breast
feeding
  Mean (SD) 4 (2) 5 (2)
  Missing 40 0
Median (range) of LEM at 12
months (ng/g lipid - months) a
  PCB153 119 (12–1,194) 126 (19–1,194)
  ΣPCBs b 546 (64–4,249) 574 (100–4,249)
  p,p’-DDT 33 (1–523) 34 (1–326)
  p,p’-DDE 871 (134–19,260) 880 (134–19,260)
Abbreviation: <LOD, lower than detection limit; p,p’-DDE, 2,2-bis(p-chlorophenyl)-1,1-dichloroethylene; p,p’-DDT, 2,2-bis(p-
chlorophenyl)-1,1,1-trichloroethane; LEM, lactational exposure metrics; PCB, polychlorinated biphenyls; and SD, standard deviation.
a
There was 1 subject missing ΣPCBs concentration and the LEM of ΣPCBs and 1 subject missing p,p’-DDT concentration and the LEM of p,p’-
DDT. Additional 40 subjects in the milk sample group were missing LEM because of missing duration of breast feeding through 12 months.
b
ΣPCBs is the sum of the concentrations of PCB66, PCB74, PCB99, PCB105, PCB118, PCB138_158, PCB146, PCB153, PCB156, PCB170,
PCB177, PCB178, PCB180, PCB183, PCB187, PCB194, PCB196_203 and PCB199, in which <LOD is treated as median(LOD) divided by a
square root of 2.
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Table 2
(Linear Mixed Effects Models) Fixed Effect Estimates of a 10 ng/g-lipid Increase in the Concentrations of
PCB153, PCBs, p,p’-DDT and p,p’-DDE in Breast Milk at 3 Months Postpartum on Infant Weight and Length
in the First 6 Months.
Chemical concentration Weight (g) Length (cm)
(per 10 ng/g lipid) β a 95% CI β a 95% CI
PCB153 −23.1 [−46.3, 0.05] −0.06 [−0.20, 0.09]
ΣPCBs −6.2 [−12.5, 0.1] −0.02 [−0.06, 0.02]
p,p’-DDT 17.6 [−91.2, 126.5] 0.17 [−0.47, 0.82]
p,p’-DDE 0.5 [−1.7, 2.8] 0.01 [−0.005, 0.02]
Abbreviation: CI, confidence interval; p,p’-DDE, 2,2-bis(p-chlorophenyl)-1,1-dichloroethylene; p,p’-DDT, 2,2-bis(p-chlorophenyl)-1,1,1-
trichloroethane; and PCB, polychlorinated biphenyls.
a
Adjusted for infant gender (male vs. female), preterm birth (yes vs. no), birthweight (grams), maternal race (nonwhite vs. white), education (<16
years vs. ≥16 years), income as a percentage of the poverty level during pregnancy (100%), parity (0 vs. ≥1), and maternal pre-pregnancy body
mass index (kg/m2). Interpretation of the β was: in the first 6 months, infant weight or length would change by β grams or centimeters as the
chemical concentration in breast milk increased by 10 ng/g lipid after adjusted for all other covariates.
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